Natriuretic mechanisms of AT2 receptors

AT2受体的利尿钠排泄机制

• 批准号: 7523729
• 负责人: ROBERT MUNSON CAREY
• 金额: $ 44.48万
• 依托单位: UNIVERSITY OF VIRGINIA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-15 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7523729
• 关键词: AGTR2 gene; ATP phosphohydrolase; Adult; Affect; Agonist; Angiotensin II; Angiotensin III; Apical; Arts; Blood Pressure; Blood Vessels; Bradykinin; Cell Proliferation; Cell membrane; Cells; Cessation of life; Cyclic GMP; Data; Disease; Dopamine D1 Receptor; Electrolyte Balance; Electrolytes; Endosomes; Enzymes; Essential Hypertension; Excretory function; Fenoldopam; Functional disorder; Goals; Growth; Heart; Homeostasis; Hormonal; Hypersensitivity; Hypertension; Kidney; Knockout Mice; Laboratories; Liquid substance; Mediating; Mediator of activation protein; Membrane; Molecular; Molecular Target; Natriuresis; Nitric Oxide; Peptides; Perfusion; Plasma; Play; Population; Principal Investigator; Proximal Kidney Tubules; Rattus; Receptor Activation; Receptor Inhibition; Recruitment Activity; Recycling; Regulation; Renal function; Renin-Angiotensin System; Risk Factors; Role; Signal Pathway; Site; Sodium; Sodium Chloride; Stimulation of Cell Proliferation; Stimulus; Techniques; Testing; Vasodilation; Water; Western World; alanine aminopeptidase; apical membrane; basolateral membrane; blood pressure regulation; cell growth; disability; hypertension prevention; in vivo; premature; pressure; public health relevance; receptor; receptor expression; response; saluretic; urinary; vasoconstriction

DESCRIPTION (provided by applicant): The renin-angiotensin system (RAS) is a hormonal cascade of major critical importance to the regulation of blood pressure, fluid and electrolyte balance and kidney function. Angiotensin II (Ang II), the main effector peptide of the RAS, acts at two major receptors, AT1 and AT2. The vast majority of Ang II actions are mediated by the AT1 receptor, including cell proliferation, vasoconstriction and antinatriuresis. Much less is known concerning the functions of the AT2 receptor. Recent studies indicate that the AT2 receptor inhibits cell growth and induces vasodilation opposing the effects of Ang II at AT1 receptors. The role of the AT2 receptors in fluid and electrolyte homeostasis is unknown. The Principal Investigator has pilot data demonstrating that the AT2 receptor mediates natriuresis and that the haptapeptide derivative of Ang II, des-aspartyl-Ang II (Ang III), is the preferred agonist. The Principal Investigator also has preliminary data strongly suggesting that dopamine D1-receptor stimulation induces increased renal proximal tubule cell apical membrane AT2 receptor expression and that inhibition of AT2 receptors abolishes D1-receptor-induced natriuresis. This project will explore in depth the site and mechanisms of AT2 receptor-induced natriuresis. The project will focus on two specific hypotheses: (1) the AT2 receptor is a key mediator of the natriuretic response to Ang III, D1 receptor activation and increased renal perfusion pressure; and (2) natriuretic responses to Ang II and D1 like receptor activation require AT2 receptor recruitment to the apical plasma membrane of renal proximal tubule cells and are mediated by bradykinin, nitric oxide and cyclic GMP. The project will apply a combination of state-of-the-art in vivo and cell and molecular techniques to clarify the role of the AT2 receptor in sodium excretion. These studies will help clarify the pathophysiology of primary hypertension, a disorder affecting one-quarter after adult population in the Western world. PUBLIC HEALTH RELEVANCE Hypertension (high blood pressure), present in over 25% of the population of the Western world, is a major risk factor for heart and blood vessel disease leading to premature death and disability. Retention of salt and water by the kidney is required for hypertension to develop. This application will increase our understanding of the mechanisms whereby the kidney renin-angiotensin system regulates salt and water excretion, suggesting new molecular targets for the treatment and prevention of hypertension.

描述(申请人提供)：肾素-血管紧张素系统(RAS)是一种荷尔蒙级联反应，对调节血压、液体和电解质平衡以及肾功能至关重要。血管紧张素II(Ang II)是RAS的主要效应肽，作用于AT1和AT2两个主要受体。血管紧张素转换酶II的绝大多数作用是由AT1受体介导的，包括细胞增殖、血管收缩和抗心绞痛。人们对AT2受体的功能知之甚少。最近的研究表明，AT2受体抑制细胞生长并诱导血管扩张，与血管紧张素转换酶II在AT1受体上的作用相反。AT2受体在体液和电解质动态平衡中的作用尚不清楚。首席调查员有初步数据表明，AT2受体介导钠尿，Ang II的半肽衍生物Des-Aspartyl-Ang II(Ang III)是首选的激动剂。首席调查者也有强有力的初步数据表明，刺激多巴胺D1受体可诱导肾近端小管细胞顶膜AT2受体表达增加，抑制AT2受体可取消D1受体诱导的利钠作用。本项目将深入探讨AT2受体诱导性钠尿的部位和机制。该项目将集中于两个具体的假设：(1)AT2受体是Ang III、D1受体激活和肾脏灌流压增加的利钠反应的关键媒介；(2)对Ang II和D1样受体激活的利钠反应需要AT2受体重新聚集到肾近端小管细胞的顶端质膜，并由缓激肽、一氧化氮和环状GMP介导。该项目将应用体内最先进的技术以及细胞和分子技术来阐明AT2受体在钠排泄中的作用。这些研究将有助于阐明原发性高血压的病理生理学，在西方世界，高血压是一种影响四分之一成年后人口的疾病。 公共卫生相关性 高血压(高血压)存在于西方世界25%以上的人口中，是导致过早死亡和残疾的心血管疾病的主要危险因素。高血压的发生需要肾脏保留盐分和水分。这一应用将增加我们对肾脏肾素-血管紧张素系统调节盐和水排泄的机制的了解，为高血压的治疗和预防提供新的分子靶点。